Dierks+Company is led by the pharmaceutical and medical device law experts and general practitioner Christian Dierks. The practice follows an intergrated and interdisciplinary approach, whereas project management and healthcare-related IT matters are also covered. The team increasingly advises at the interface with public matters, which leads to frequent instructions in the context of legislative proposals. This is complemented by expertise in the development and establishment of innovative products as well as digital healthcare services, including data protection issues. Steffen Schröder is a key contact for matters pertaining to the global distribution of medicines as well as the research and development of medicines and their international licensing. In October 2023, counsel Katrin Helle (regulatory law) joined the team at White & Case LLP, while Dominik Roters, general counsel and deputy managing director of the Federal Joint Committee (G-BA), joined the team in January 2024; he is experienced in advising on pharmaceuticals and statutory health insurance.
Testimonials
Collated independently by Legal 500 research team.
- 'Very experienced teams - always with the correct breadth and depth in the requested topics - top!'
- 'Our experiences have been positive all around, response times are quick and the service overall is very positive.'
Key clients
- Aignostics GmbH
- Alexion Pharma Germany GmbH
Work highlights
- Support for change4RARE in the initiative of the same name, through which knowledge about the care of rare diseases is bundled with the active involvement of various specialist disciplines and perspectives and made accessible to an interested (professional) public; Advice, among other things, on the design of the initiative as well as the content and structural development; In addition, strategic support of the communication campaign.
- Support in setting up the NUM (National Network for University Medicine), including all essential contracts and data protection documents.